Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.

Antonella d'Arminio MonforteAlessandro Cozzi-LepriFrancesca Ceccherini-SilbersteinAndrea De LucaSergio Lo CaputoAntonella CastagnaCristina MussiniAntonella CingolaniAlessandro TavelliMilensu ShanyindeAndrea GoriEnrico GirardiMassimo AndreoniAndrea AntinoriMassimo Puotinull null

Published in: PloS one (2017)

Only 35.3% had access to HCV treatment. Despite excellent rates of SVR12 rates (91.6%), only 21% (545/2,607) of our HIV-HCV co-infected patients are cured.

Keyphrases

hepatitis c virus
human immunodeficiency virus
antiretroviral therapy
hiv positive
hiv infected
hiv testing
hiv aids
men who have sex with men
electronic health record
machine learning
combination therapy
artificial intelligence